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Curcuma aromatica Salisb. (Family: Zingiberaceae) is a species
occurring wild throughout India and cultivated chieﬂy in West
Bengal and Travancore. The plant is commonly known as
Jungalee Haldi (wild turmeric). The rhizomes are light yellow
(internally orange) and possess a camphoraceous odour. They
are sometimes used as a substitute for turmeric (Curcumaess: 15, Senior MIG, Vikram
Pradesh, India. Tel.: +91
rediffmail.com (H. Misra),
y. Production and hosting by
Saud University.
lsevierlonga). C. aromatica is never used as a spice but only as an aro-
matic for cosmetic purposes and in indigenous medicine for
external applications on skin diseases, bruises and sprains
(Anon., 1950; Maheshwari and Singh, 1965).
The colouring matter in the rhizomes of C. aromatica is pre-
dominantly curcumin (Rao and Shintre, 1928) and demethoxy-
curcumin, a trace of bis-demethoxycurcumin can be found
when high levels of samples are taken for thin layer separation
(Tonnesen et al., 1992). It has generally a higher level of vola-
tile content (4–8%) and lower curcuminoids (1.5%). The
chemical and aroma characteristics of the volatile oil of two
species are so different that C. aromatica cannot be substituted
for C. longa in its food use. Thin-layer chromatography (TLC),
gas chromatography (GC) could easily detect the accidental or
deliberate admixture of C. aromatica in C. longa due to the
presence of camphene and camphor and a high boiling alcohol
in the volatile oil of C. aromatica, which are absent in C. longa
(Govidarajan, 1980; Raghuveer and Govindarajan, 1979; Sen
et al., 1974).
C. aromatica is used for preventing and treating coronary
heart disease (Chemical Abstracts, 1990, 1985a,b), for epilepsy
(Chemical Abstracts, 1989), as anti-allergic and in autoimmune
diseases (Chemical Abstracts, 1996a,b; Dai et al., 1982).
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ics for bruises, sprains, hiccough, bronchitis, cough, leucoderma
and skin eruptions (Warrier et al., 1993-1995). Rhizomes yield
6.1% essential oil (Chopra et al., 1980) and exhibited anti-tumor
activity (Wu et al., 2000). Oil is also used for treatment of early
stage of cervix cancer (Asolkar et al., 1992). The constituents
identiﬁed in the oil were: a-pinene, b-pinene, camphene, 1,8-ci-
neol, isofurano-germacrene, borneol, isoborneol, camphor, ger-
macrone and tetramethylpyrazine (Guo et al., 1980). The
extracts ofC. aromatica roots ﬁnd uses for the treatment of cho-
lecystitis, biliary calculi and other related diseases (Chemical
Abstracts, 1987). Various other reported activities includes anti-
microbial (Banerjee et al., 1978) and anti-tumor (Su et al., 1980)
activities of essential oil, anti-inﬂammatory activity due to
curcumin (Chan et al., 1998), anti-diabetic due to (4S,5S)-
(+)-germacrone-4,5-epoxide (Chemical Abstracts, 1994) and
anti-arrhythmic activity of aqueous extract due to the presence
of dipotassium magnesium dioxalate dihydrate (Zhen et al.,
1982; Chemical Abstracts, 1985a,b). Curdione, neocurdione,
curcumol, tetramethyl pyrazine and (R)-(+)-1, 2-hexadecane-
diol were isolated from C. aromatica (Huang et al., 2000).
Recently, the chemical composition of the hydro-distilled essen-
tial oil from leaves of C. aromatica was established, where 23
compounds representing 94.29% of the total oil were identiﬁed.
The antioxidant activities of the oil and various extracts of
C. aromatica were evaluated by using 2,2-diphenyl-1-pic-
rylhydrazyl (DPPH) and superoxide radical-scavenging assays.O
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Figure 1 Chemical structures of Curcumin (1), DemethoxycThe oil and methanol extract showed potent DPPH radical-
scavenging activities (IC(50) = 14.45 and 16.58 lg/mL, respec-
tively), which were higher than butylated hydroxyanisole
(IC(50) = 18.27 lg/mL. The extracts also exhibited remarkable
superoxide radical-scavenging activities (IC(50) = 22.6–45.27
lg/mL and the activity in the methanol extract was superior to
all other extracts (IC(50) = 22.6 lg/mL (Al-Reza et al., 2010).
In course of search for biologically active substances, the
present work was undertaken to isolate and characterize phy-
tochemicals from the rhizomes of C. aromatica. Ethyl acetate
extract, fractionated from hydromethanolic extract of plant
material after defatting with hexane, yielded three secondary
metabolites namely, curcumin 1, demethoxycurcumin 2 and
b-sitosterol-3-O-b-D-glucopyranoside 3 (Fig. 1). Of these com-
pounds, 3 is isolated for the ﬁrst time from C. aromatica.
2. Materials and methods
2.1. General procedures
Melting point was determined on electro thermal (UK-made)
apparatus on centrigrade scale and was uncorrected. Ultra-vio-
let absorption spectrum was recorded on Perkin–Elmer Lamb-
da Bio 20 UV spectrophotometer. Infrared spectrum was
recorded on Perkin–Elmer 1710 infrared Fourier Transform
spectrometer. 1H and 13C NMR was recorded on a Bruker
AVANCE DRX-300 (300 and 75 MHz) equipped with 5 mmO
OH
OMe
3'
4'
9'
10'
 (Curcumin) 
emethoxycurcumin) 
6
7
8
9
12
13
14 15
1617
18 20
21 22
23
24 25
26
27
28
29
urcumin (2) and b-sitosterol-3-O-b-D-glucopyranoside (3).
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was used as an internal standard and chemical shift values
are expressed in d (ppm) values, coupling constant (J) in Hertz.
ESMS, electro spray mass spectra, was recoded on a Micro-
mass Quattro II triple quadrapole mass spectrometer. EIMS,
electron impact mass spectra, was recorded at 70 eV on
JEOL-JMS D-100 spectrometer. Column chromatography
was performed over silica gel (60–120 mesh, Qualigen) and
TLC was carried out on a silica gel G (10–40 lm, Merck). Pa-
per chromatography (PC) was carried out on Whatman paper
number 1 in descending mode in n-BuOH:AcOH:H2O (4:1:5,
v/v/v), developed by spraying with silver nitrate solution in
acetone followed by NaOH solution in methanol.
2.2. Plant material
The rhizome of C. aromatica was collected from Assam (Goal
Para, Lakhimpur) and was identiﬁed by the Botany and Phar-
macognosy Division of Central Institute of Medicinal and
Aromatic Plants (CIMAP), Lucknow (India), where a voucher
specimen has been retained.
2.3. Extraction and isolation
The air-dried and powdered rhizomes (4.50 kg) ofC. aromatica
were extracted with n-hexane (2.5 L · 6) and defatted marc
was then extracted with aqueous methanol (90%) at room tem-
perature (3 L · 10). The aqueous methanolic extract thus ob-
tained was concentrated to dryness (150 g) and subjected to
fractionation with different solvents of increasing polarity
viz., chloroform, ethyl acetate, methanol and n-butanol in a
soxhlet apparatus. Evaporation of solvent under reduced pres-
sure yielded different extracts 117.96 g chloroform extract,
5.71 g ethyl acetate extract, 7.11 g methanol extract and
17.04 g n-butanol extract, respectively. We have carried out
investigation of ethyl acetate extract as it showed six spots
on TLC plate developed in chloroform:methanol (95:5). Spots
were visualized by spraying TLC plate with 10% H2SO4 fol-
lowed by heating at 110 C for 5–10 min. Ethyl acetate extract
(5.71 g) was subjected to column chromatography. Elution of
the column made by using chloroform:methanol [100:0 (frac-
tions 1–7), 99:1 (fractions 8–12 and 13–19), 97:3 (fractions
20–24 and 25–30), 95:5 (fractions 31–38), 93:7 (fractions 39–
42) and 90:10 (eluted further)].
2.3.1. Compound 1 (curcumin)
Preparative TLC of fraction no. 13–19 yielded compound 1,
which was crystallized in chloroform. Yield of 1 (5 mg), m.p.
184–186 C; IRmmax: 3448 (OH), 2967, 2865, 1631 (C‚O),
1605, 1524, 1460, 1431, 1381, 1280, 1233, 1205, 1182,
1155 cm1. UV kmax: 240, 420 nm.
1H NMR (CDCl3, d): 1.30
(2H, br s, H-1), 6.52 (2H, brs, H-3/H-30), 6.90 (2H, br s, H-4/
H-40), 7.14 (2H, d, J= 10.5 Hz, H-9/H-90), 7.65 (2H, d, J=
10.5 Hz, H-10/H-100), 3.30 (6H, s, OCH3 · 2). EIMS: m/z 368
[M]+ C21H20O6.
2.3.2. Compound 2 (demethoxycurcumin)
Compound 2 was obtained along with compound 1 in very low
yield (3.0 mg) by preparative TLC of fraction no. 13–19 and
re-crystallized in chloroform. m.p. 168–170 C, IRmmax: 3448
(OH), 2967, 2865, 1631 (C‚C), 1605, 1524, 1460, 1431,1381, 1280, 1233, 1205, 1182, 1155 cm1; UV kmax: 251,
423 nm. 1H NMR (CDCl3, d) 1.30 (2H, br s, H-1), 6.53 (2H,
br s, H-3/H/30), 6.93(2H, br s, H-4/H-40), 7.46 (2H, br s, H-
9/H-90), 7.66 (2H, br s, H-10/H-100), 3.93 (3H, s, OCH3);
EIMS: m/z 338 [M]+ C20H18O5.
2.3.3. Compound 3 (b-sitosterol-3-O-b-D-glucopyranoside)
Compound 3 was obtained as crystalline solid while eluting the
column with chloroform:methanol (95:5) from fraction no. 6
as white solid. It was crystallized in chloroform:methanol
(90:10). Yield 27.0 mg. Rf 0.56 (chloroform:methanol 88:12),
m.p. 248 C (d), IRmmax: 3410 (OH), 2961, 1634 (C‚C),
1450, 1256, 1197, 1168, 1070, 973 cm1; 1H NMR (Py-d5, d)
0.75, 0.78, 0.86, 0.93, 1.00, 1.19, (3H each, s, -CH3 · 6),
3.45–4.25 (6H, m, –CH and CH2 of glucose), 5.07 (1H, d,
J= 7.5 Hz, H-10), 5.37 (1H, m, H-6), 13C NMR (py-d5, d)
37.5 (C-1), 30.6 (C-2), 78.7 (C-3), 40.0 (C-4), 141.0 (C-5),
122.0 (C-6), 32.2 (C-7), 32.1 (C-8), 50.4 (C-9), 37.0 (C-10),
21.3 (C-11), 28.6 (C12), 42.5 (C-13), 56.9 (C-14), 24.5 (C-15),
39.4 (C-16), 56.3 (C-17), 12.0 (C-18), 19.5 (C-19), 36.4 (C-
20), 19.3 (C-21), 36.4 (C-22), 34.2 (C-23), 46.1 (C-24), 29.5
(C-25), 19.1 (C-26), 20.0 (C-27), 26.4(C-28), 12.2 (C-29), Glc
moiety: 102.6 (C-10),75.4 (C-20), 78.5 (C-30), 76.6 (C-40), 78.1
(C-50), 62.9 (C-60), EIMS: m/z 414 [Mglc]+, 399 [MCH3]+,
396 [MH2O]+, 381, 271, 373, 255, 231, 213, 187, 161, 150,
134, 107, 92, 79, 43.
2.3.4. Hydrolysis of compound 3
Compound 3 (10 mg) was reﬂuxed with 5% methanolic HCl
(10 ml) for 4 h. After the completion of the reaction, the mix-
ture was diluted with water (10 ml) and extracted with chloro-
form (3 · 15 ml) and dried over anhydrous sodium sulphate. It
was then ﬁltered and the solvent was evaporated to furnish the
aglycone part identiﬁed as b-sitosterol m.p. 136 C [M]+ m/z
414. Aqueous mother liquor was neutralized with barium car-
bonate and ﬁltered. The ﬁltrate was then concentrated and
identiﬁed as D-glucose (Co-PC with authentic sample).3. Results and discussion
3.1. Compound 1 (curcumin)
Compound 1 was obtained as orange prisms by crystallization
with chloroform, m.p. 184–186 C. The IR spectrum indicated
the presence of a hydroxyl group (3448 cm1), a carbonyl
group at 1631 cm1 and a band at 1524 cm1 for double
bonds. The compound showed UV absorption at 240,
420 nm for the presence of an a, b-unsaturated carbonyl
group. The EIMS at m/z 368 corresponded to the molecular
formula C21H20O6. A broad singlet at d 6.52 1.30 (2H) in
1H
NMR was assigned for C-1 proton. Two broad singlets at d
6.52 and 6.90 were assigned for magnetically equivalent H-3/
H-30 and H-4/H-40 protons, respectively. The ortho-coupled
protons of the aromatic ring appeared as doublets at d 7.14
and 7.65 (J= 10.5 Hz each) assigned for H-9/H-90 and
H-10/H-100, respectively, present in identical environment.
The methoxyl protons appeared at d 3.30 (6H) as a singlet.
The compound was characterized as 1,7-bis-(4-hydroxy-
3-methoxyphenyl)-1,6-heptadiene-3,5-dione (curcumin) on
comparison with the authentic sample and reported data
(Govidarajan, 1980; Ali et al., 1995).
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Figure 2 EI-MS fragmentation pattern of aglycone moiety
(b-sitosterol) of b-sitosterol-3-O-b-D-glucopyranoside (3).
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Compound 2 was obtained as orange yellow powder by pre-
parative TLC in very low yield (3.0 mg), m.p. 168–170 C.
The IR spectrum of the compound showed the presence of
O–H stretching at 3448 cm1 and a band at 1631 cm1 for
the presence of a double bond. Compound also showed posi-
tive UV bands at 251 and 423 nm for the presence of conju-
gated aromatic system present in it. The EIMS at m/z 338
suggested the molecular formula C20H18O5. The
1H NMR of
the compound showed similar shift values as for compound
1 but it showed the presence of only one methoxy group placed
at d 3.93 as a singlet. The spectral values were in good agree-
ment with those reported in the literature (Ali et al., 1995).
The molecular ion peak at m/z 338 was inconsistent with the
present structure having deﬁciency of 30 mass units (methoxy
group) from compound 1. This further authenticated the
proposed structure. Thus, the compound was characterized
as 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-
heptadiene-3,5-dione (demethoxycurcumin) in comparison
with the authentic sample and reported values (Govidarajan,
1980).
3.3. Compound 3 (b-sitosterol-3-O-b-D-glucopyranoside)
Compound 3 was obtained while eluting the column with chlo-
roform:methanol (95:5) as crystalline solid, m.p. 248 C (d). It
showed positive Liebermann Bucchard (LB) and positive
Feigl’s test, suggesting for the presence of a steroidal glycoside.
The IR spectrum of 3 exhibited a broad band at 3410 cm1 for
the presence of a hydroxyl group and a band at 1634 cm1 for
the double bond. The other bands obtained were at 2961, 1450,
1256, 1197, 1168, 1070, and 973 cm1 The molecular ion peak
were not observed in the EIMS of this compound as the mol-
ecule provides an ion at m/z 414 in consistent with the aglycone
moiety. The 1H NMR showed six singlets at d 0.75, 0.78, 0.86,
0.93, 1.00 and 1.19 (3H each) for the presence of six methyl
groups in the compound. The spectrum further revealed broad
signals between d 3.45 and 4.25 (6H, m) for the presence of –
CH and CH2 groups of the sugar moiety. A doublet at 5.07
(J= 7.5 Hz) was observed for the anomeric proton. A multi-
plet at d 5.37 was observed for H-6 proton. The 13C NMR
of the compound showed the presence of 35 intense carbon sig-
nals. The DEPT experiment indicated the presence of 14
methine, 12 methylene, 6 methyl and 3 quaternary carbons.
The lesser number of methyl and higher number of methylenes
suggested that it is not a triterpene and may be a steroid.
Acid hydrolysis of the compound afforded aglycone, m.p.
136 C. [M]+ m/z 414 identiﬁed as b-sitosterol and the glycone
moiety identiﬁed as D-glucose by Co-PC with the authentic
sample. The presence of four methane signals at d 75.4, 76.6,
78.1, and 78.5 ppm, one methylene at d 62.9 ppm and a
methine signal at d 102.6 ppm in 13C NMR further conﬁrmed
the presence of glucose in the molecule. The EIMS of aglycone
moiety showed fragments (Fig. 2) at m/z 273 [M-side chain]+,
23 [273-42 (ring D)]+, 161 [273-70 (ring C)]+, 107 [161-54 (ring
B)]+, 92 [107-15 (CH3)]
+ which are characteristic for sitoster-
ols (Aizawa et al., 1974). Since the aglycone moiety is sitosterol
and glycone is D-glucose, therefore, the compound 3 must be a
3-O-glucoside of sitosterol and the linkage of C-3 hydroxyl
group to anomeric carbon of glucose moiety is b- which was
conﬁrmed from the coupling constant of anomeric proton atd 5.07 (J= 7.5 Hz) in its 1H NMR spectrum. On the basis
of above evidences and comparison of spectral data with those
reported in the literature (Srivastava, 1998) structure of com-
pound 3 was characterized as b-sitosterol-3-O-b-D-glucopyran-
oside. This compound is being reported for the ﬁrst time from
C. aromatica.
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